Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Donald Trump
Fierce Healthcare
No deal in sight following high-stakes White House negotiations
ACA subsidies remain a sticking point, though Schumer said the president appears more amenable to a compromise than other Republicans.
Dave Muoio
,
Emma Beavins
Sep 29, 2025 6:00pm
HHS division refers Harvard for potential debarment
Sep 29, 2025 4:59pm
Trump administration launches tariff probe into medtech industry
Sep 25, 2025 2:30pm
Alternate history of NIH reveals potential impact of agency cuts
Sep 25, 2025 2:00pm
Massachusetts most impacted by NIH research cuts: Grant Witness
Sep 18, 2025 9:38am
Fierce Pharma
Under Trump, FDA seeks to abandon expert reviews of new drugs
Sep 12, 2025 9:50am